(PRWEB) April 25, 2013
The US Drug Watchdog is taking a revolutionary approach to helping women in any US state, who are victims of a severe transvaginal mesh failure by offering them the names of the best possible attorneys, and because the damages are so personal, the group is promising the attorneys will all be women. The US Drug Watchdog is saying, "This is by far the most horrific medical device failure we have ever heard of. The US FDA is now saying transvaginal mesh, tape, or sling failures are causing complications in patients such as erosion and infection. Women who experience transvaginal mesh failure may need to have numerous corrective surgeries, IV therapy, blood transfusions and drainage of hematomas or abscesses." The US Drug Watchdog is urging victims of a transvaginal mesh failure that involve severe medical complications to call them anytime at 866-714-6466 for more information.
The US Drug Watchdog is now saying, "Symptoms of a transvaginal mesh, tape, or sling implant failure may include: severe pain during sexual intercourse caused by erosion, mesh erosion through the vagina (the mesh is actually protruding out of the vaginal wall), vaginal bleeding,, vaginal infection, urinary problems, and or non stop UTI's, organ perforation, hardening of the vaginal mesh, injury to nearby organs, and or severe pelvic pain. We want to emphasize there are victims coast, to coast, from New York to California, Ohio, Texas, Washington, Florida, Massachusetts, Nebraska, Oklahoma, and every other state, and we want to hear from them." For more information please call the US Drug Watchdog at 866-714-6466. http://USDrugWatchdog.Com
U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)
Read the full story at http://www.prweb.com/releases/2013/4/prweb10650819.htm.
Copyright©2012 Vocus, Inc.
All rights reserved